Here’s what you should know:
1. Analysts report the market reached $9.9 billion in 2017, and expect it to rocket to $22.6 billion by 2022.
2. The market’s growth is hinging on the growth of a number of emerging treatments.
3. Market growth could be hindered by regulatory issues.
4. BCC Research analyst and report author Melissa Elder said, “A concentrated effort is needed to educate providers and payers about the value and potential cost savings of effective pain management. As the industry continues to focus on cost-effective pain management, finding treatments that have minimal side effects and control pain effectively will be the most valuable to providers and patients. Many studies have shown good pain management reduces complications and hospital lengths of stay, with significant savings that far exceed the cost of the technology or drugs used.”
More articles on anesthesia:
6 new GI-driven ASCs and facilities — January 2018
7 things for ASC leaders to know for Thursday — Feb. 22, 2018
A 30k-foot view of technology — Dr. Arnold Levy shares why GI practices need to embrace technology now
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.